Form 4: Teladoc Health Interim CAO James L. Cave Reports Stock Transactions
SEC Form 4 Filing
James L. Cave, Interim CAO of Teladoc Health, reports the acquisition and disposal of common stock and restricted stock units.
Summary
- On August 30, 2024, James L. Cave, Interim CAO of Teladoc Health, engaged in multiple transactions involving Teladoc Health's common stock and restricted stock units.
- These transactions included the vesting of restricted stock units and the subsequent acquisition of common stock.
- Cave also disposed of 555 shares of common stock on September 3, 2024, at a price of $7.164 per share to cover tax withholding obligations related to the vesting of restricted stock units.
- Following these transactions, Cave directly owns 13,808 shares of Teladoc Health common stock and 6,977 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by an insider. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It doesn't necessarily reflect a broader industry trend but is specific to the individual's transactions and company's stock performance.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in insider ownership.
- The sale of shares to cover tax obligations is a common practice and unlikely to significantly affect the company's operations or financial stability.
Key Dates
| Date | Description |
|---|---|
| 04/01/2022 | Reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 06/01/2022 | Reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/03/2023 | Reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 08/30/2024 | Transactions involving common stock and restricted stock units occurred. |
| 09/03/2024 | 555 shares were disposed of at $7.164 per share to cover tax obligations. |
| 09/04/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.